Near Infrared Imaging Market by Clinics, Research Laboratory and Pharmaceutical Companies Analysis by Cancer Surgery, Plastic Surgery, Gastrointestinal Surgery, Fluorescence Imaging to 2024 - Emerging Trends, Industry Forecast, Segmentation and Top Techno

Near-infrared imaging market report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or a combination of the below mentioned five strategies.

Download Free PDF Brochure of Near Infrared Imaging Market Report Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=503638 .

Report analyzes the near-infrared imaging market and aims at estimating the market size and its future growth potential in various product, application, end user, and regional segments. The report also includes the competitive analysis of key market players along with their company profiles, product offerings, recent developments, and key market strategies.

The near-infrared imaging market is valued at an estimated USD 416 million in 2018 and is projected to grow at a CAGR of 14.6% during the forecast period of 2018 to 2023, to reach USD 822 million by 2023. The growth of this market is driven by the increasing number of surgical procedures globally and the advantages of NIR imaging over conventional visualization methods.

The near-infrared imaging market is segmented into hospitals & clinics, research laboratories, and pharmaceutical & biotechnology companies. Hospitals & clinics are estimated to form the fastest-growing end-user segment in this market majorly due to the increasing prevalence of cancer and the rising number of plastic and reconstructive surgeries performed in hospitals and clinics.

Inquire for Discount on Near-Infrared Imaging Market Report Now at https://www.reportsnreports.com/contacts/discount.aspx?name=503638 .

The near-infrared imaging reagents market is segmented into indocyanine green (ICG) and other reagents. The indocyanine green segment is expected to grow at a higher CAGR during the forecast period owing to the fact that ICG is the only approved fluorescent dye for clinical use with all key products such as SPY elite, PINPOINT, and SPY-PHI. Also, ICG is cost-effective and has potentially no adverse effects.

Devices segment to dominate the near-infrared imaging market, by product. Based on product, the market is segmented into devices and reagents. In 2018, the devices segment is expected to account for a larger share of the near-infrared imaging market majorly due to the rising prevalence of cancer and the increasing number of research activities on cancer.

Competitive Landscape
1 Introduction
2 Market Share Analysis
3 Competitive Leadership Mapping
4 Visionary Leaders
5 Innovators
6 Dynamic Differentiators
7 Emerging Companies
8 Competitive Scenario
9 Competitive Scenario and Trends
10 Changing Competitive Landscape as Large Corporations Enter the NIR Imaging Market
11 Product Launches and Approvals
12 Expansions
13 Agreements, Collaborations, and Partnerships
14 Acquisitions

The key players operating in the near-infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus (Japan), Fluoptics (France), Hamamatsu Photonics K.K (Japan), Quest Medical Imaging B.V. (Netherlands), Mizuho Medical Co, Ltd. (Japan), Shimadzu Corporation (Japan), Visionsense (Israel), PerkinElmer, Inc. (US), LI-COR, Inc. (US), and SurgVision (Netherlands).

More Information on “Near Infrared Imaging Market by Product Type (NIR Fluorescence Imaging, Reagents), Application (Cancer surgery, Plastic surgery, Gastrointestinal surgery) End Users (Hospitals & Clinics, Research laboratory, Pharmaceutical companies) - Global Forecast to 2023” report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=503638 .

North America is the major revenue generating region in the near-infrared imaging market. The near-infrared imaging market in North America is driven by the high healthcare spending, rising geriatric population, rising prevalence of target diseases, increasing number of cosmetic surgeries, and the rapid adoption of technologically advanced imaging systems in the region.

Breakdown of primary participants:
• By Company Type: Tier 1–55%, Tier 2–25%, and Tier 3–20%
• By Designation: C-level–43%, Director-level–32%, and Others–25%
• By Region: North America–38%, Europe–23%, Asia Pacific–29%, and Rest of the World–10%

Medtronic acquired VisionSense, an Israel-based company engaged in the development of imaging and visualization solutions for minimally invasive surgeries. This allowed the company to gain access to VisionSense’s near-infrared imaging devices. The acquisition of Surgvision has expanded Bracco’s portfolio of imaging solutions for healthcare professionals in oncology. Stryker acquired NOVADAQ Technologies Inc., a leading developer of fluorescence imaging technologies providing surgeons with the visualization of blood flow in vessels and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures, for USD 701 million. This strategic acquisition made Stryker a leading player in the near-infrared imaging market.

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.